Other languages Kingworld Medicines Group Limited

Equities

1110

KYG5268M1006

Market Closed - Hong Kong S.E. Other stock markets 04:08:28 2024-05-20 EDT			5-day change	1st Jan Change
0.64 ^HKD	+3.23%		+10.34%	+1.59%

04-23	Kingworld Medicines Posts 68% Jump in 2023 Profit	MT
03-26	Kingworld Medicines Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Kingworld Medicines Posts 68% Jump in 2023 Profit	04-22
Kingworld Medicines Group Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 28 June 2024	03-27
Kingworld Medicines Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023	03-26
Kingworld Medicine Expects Up to 75% Profit Jump in 2023; Shares Up 6%	03-21
Kingworld Medicines Group Limited Provides consolidated Earnings Guidance for the Year Ended 31 December 2023	03-20
Kingworld Medicines Group Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28
Kingworld Medicines Group Expects Up to 40% Rise in H1 Profit	23-08-02
Kingworld Medicines Group Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 June 2023	23-08-02
Kingworld Medicines Group Limited Approves Final Dividend for the Year Ended 31 December 2022	23-05-29
Kingworld Medicines to Invest 832 Million Yen in Taiko Pharmaceutical	23-04-25
Kingworld Medicines to Grant 3.5 Million Awarded Shares Under 2019 Scheme	23-04-07
Kingworld Medicines Group Limited Proposes Ordinary Final Dividend for the Year Ended 31 December 2022, Payable on 30 June 2023	23-03-30
Kingworld Medicines Group Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30
KIngworld Medicines Group Acquires 60% Stake in Innopharm	22-10-16
Kingworld Medicines Completes Topping Out Process of Longde Health Industrial Park	22-10-10
Kingworld's H1 Profit Jumps	22-09-14
Kingworld Medicines Group Limited Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-31
Kingworld Medicines Group Forecasts Up To 25% Rise in H1 Net Profit	22-08-11
Kingworld Medicines Group Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 June 2022	22-08-10
Kingworld Medicines Group Limited Announces Final Cash Dividend for the Financial Year Ended 31 December 2021, Payable on 30 June 2022	22-05-27

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Kingworld Medicines Group Limited

Equities

1110

KYG5268M1006

Other languages

Filters